China SXT Pharmaceuticals, Inc. Announces Share Consolidation

China SXT Pharmaceuticals (Nasdaq: SXTC) will effect a 1-for-150 share consolidation of its Class A ordinary shares, effective February 3, 2026.

Rhea-AI Summary

China SXT Pharmaceuticals (Nasdaq: SXTC) will effect a 1-for-150 share consolidation of its Class A ordinary shares, effective February 3, 2026. The company expects Class A shares to trade on Nasdaq under SXTC with new CUSIP G2161P165 at market open on that date.

Prior to consolidation 143,693,892 Class A shares were outstanding; after consolidation approximately 957,960 shares are expected. Fractional shares will be rounded up. Outstanding options, warrants and purchase rights will be adjusted proportionately. Shareholders holding shares through brokers will see automatic adjustments; contact Transhare Corporation for transfer-agent support.

Positive

• Share count reduced from 143,693,892 to ~957,960 shares
• Post-consolidation trading continues on Nasdaq under the same ticker SXTC

Negative

• Fractional shares rounded up, slightly increasing post-consolidation share count
• Outstanding options and warrants will be adjusted, creating administrative complexity

Argus Jan 30 session

-38.00% close to close Open Argus

Details

News Market Reaction – SXTC

On Jan 30, the day this news came out, SXTC closed 38.00% below the previous close.

Data tracked by StockTitan Argus for the Jan 30 session.

Key Figures

Share consolidation ratio: 1-for-150 Pre-consolidation shares: 143,693,892 shares Post-consolidation shares: approximately 957,960 shares +5 more

Share consolidation ratio

1-for-150

Ordinary share consolidation effective February 3, 2026

Pre-consolidation shares

143,693,892 shares

Class A ordinary shares outstanding before consolidation

Post-consolidation shares

approximately 957,960 shares

Class A ordinary shares expected after consolidation

Effective date

February 3, 2026

Date share consolidation becomes effective and trading on new basis

Current price

$0.05

Pre-news close vs. consolidation announcement

52-week high

$7.84

Pre-news price sat 99.36% below this level

Shelf registration capacity

$600,000,000

Form F-3 shelf filed November 10, 2025

Market cap

$8,833,915

Pre-news equity value at $0.05 share price

Historical Context

3 past events · Latest: Jan 15

3 events

1. Jan 15

   AI initiative

   24h Move

   +10.2%

   Announced AI Insight Initiative for TCM raw-material supply chain optimization.

2. Jan 09

   Capital raising

   24h Move

   -87.9%

   Announced $10M registered direct offering at $0.15 per share with warrants.

3. Jan 08

   AI initiative

   24h Move

   -37.5%

   Launched strategic AI Insights Initiative for portfolio planning and AI clinics.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

share consolidation, cusip number, stock options, warrants, +1 more

5 terms

share consolidation financial

"today announced that it will effect a share consolidation of its ordinary shares"

Share consolidation is a process where a company reduces the total number of its shares by combining multiple existing shares into a smaller number of higher-value shares. This can make each share more expensive and potentially improve the company’s image. For investors, it often means their ownership remains the same, but the value of each share increases, which can influence how the stock is perceived and traded.

cusip number regulatory

"under the symbol “SXTC” with the new CUSIP number G2161P165"

A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

stock options financial

"All outstanding stock options, warrants and other rights to purchase the Company's"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

warrants financial

"All outstanding stock options, warrants and other rights to purchase the Company's"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

View in glossary

transfer agent regulatory

"or the Company's transfer agent, Transhare Corporation, by calling +1 303-662-1122"

A transfer agent is a financial service that keeps the official record of who owns a company's shares, handles the buying and selling of those shares on paper or electronically, and issues or cancels stock certificates. Think of it as the company’s records keeper and mailroom combined—investors rely on it to make sure dividends, shareholder mailings, ownership changes, and proxy voting are processed accurately and securely, which protects ownership rights and helps prevent errors or fraud.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that it will effect a share consolidation of its ordinary shares at a ratio of 1-for-150, effective on February 3, 2026 (the “Share Consolidation”). The Company’s Class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on February 3, 2026. Upon the market opening on February 3, 2026, the Company’s Class A ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol “SXTC” with the new CUSIP number G2161P165.

Prior to the Share Consolidation, 143,693,892 Class A ordinary shares are issued and outstanding. As a result of the Share Consolidation, every 150 shares (or part thereof) will be combined into one (1) share, with fractional shares rounded up to the next whole share, and approximately 957,960 Class ordinary shares will be issued and outstanding after the Share Consolidation. The Company is authorized to issue an unlimited number of shares, divided into two Classes consisting of: (i) Class A ordinary shares with no par value and (ii) Class B ordinary shares with no par value. All outstanding stock options, warrants and other rights to purchase the Company's Class A ordinary shares will be adjusted proportionately as a result of the Share Consolidation.

Upon the effectuation of the Share Consolidation, shareholders holding shares through a bank, broker or other nominee will have their shares automatically adjusted to reflect the Share Consolidation.  Beneficial holders may contact their bank, broker or nominee for more information. Please direct any questions to your broker or the Company's transfer agent, Transhare Corporation, by calling +1 303-662-1122.

About China SXT Pharmaceuticals, Inc.

Founded in 2005 and headquartered in Taizhou City, Jiangsu Province, China, China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces, which is a type of Traditional Chinese Medicine that has been processed to be ready for use. For more information, please visit www.sxtchina.com.

Safe Harbor Statement

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. The Company’s actual results may differ materially from those expressed in any forward-looking statements as a result of various factors and uncertainties. The reports filed by the Company with the Securities and Exchange Commission discuss these and other important factors and risks that may affect the Company’s business, results of operations and financial conditions. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Feng Zhou, Chief Executive Officer

Email: fzhou@sxtchina.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the 1-for-150 share consolidation mean for SXTC shareholders?

It combines every 150 Class A shares into one post-consolidation share. According to the company, shareholders will hold fewer shares with proportionately higher per-share amounts, and fractional shares will be rounded up to the next whole share.

When will SXTC shares trade on a post-consolidation basis on Nasdaq?

SXTC shares will trade on a post-consolidation basis beginning at the market open on February 3, 2026. According to the company, the new CUSIP will be G2161P165 and the ticker remains SXTC.

How many SXTC Class A shares will be outstanding after the consolidation?

Approximately 957,960 Class A ordinary shares are expected to be outstanding after the consolidation. According to the company, this follows consolidation of 143,693,892 pre-consolidation shares at a 1-for-150 ratio.

Will my SXTC stock held in a brokerage account be adjusted automatically?

Yes, shares held through banks, brokers or nominees will be adjusted automatically to reflect the share consolidation. According to the company, beneficial holders should contact their broker or Transhare Corporation for any transfer-agent questions.

How will outstanding SXTC options and warrants be affected by the consolidation?

All outstanding stock options, warrants and rights will be adjusted proportionately as a result of the consolidation. According to the company, exercise prices and share counts of those instruments will be changed to reflect the 1-for-150 ratio.